期刊文献+

真核质粒在组织细胞内的表达时效

Expressive Time of Eucaryon Plasmid in Body Cells
在线阅读 下载PDF
导出
摘要 目的观察真核质粒在机体细胞内的表达时效,为临床基因治疗的给药间隔提供理论依据。方法取PCDNA3.1(+)-EGFP,pEGFP-C3,pIRES-GFP 3种绿色荧光真核质粒,利用脂质体2000转染机体细胞,观察绿色荧光蛋白在细胞的表达时间推断质粒在机体内的表达时效。结果 3组绿色荧光均在12 h开始表达,48 h达高峰,持续35 d后衰减。结论在基因治疗中真核质粒连接目的基因能在机体细胞内稳定表达35 d,基因给药间隔可选定为30 d。 Objective To observe the expressive time of eucaryon plasmid in the body cell to provide theoretical basis for interval dose of clinical gene therapy. Methods The three kinds of green fluorescence eucaryon plasmid, PCDNA3. 1 ( + )-EGFP, pEGFP-C3, pIRES-GFP were added in the liposome 2000 to transfect the body ceils and observe the expressive time of the green fluorescence to decide the expressive time of plasmid in vivo. Results The green fluorescence of the three group was expressed in 12 hours, reaching peak in 48 hours and beginning to fade after 35 days. Conclusion The objective gene on the eucaryon plasmid can express 35 days stably in the body cells, so the gene interval dose is determined as 30 days.
出处 《河南科技大学学报(医学版)》 2012年第3期180-182,共3页 Journal of Henan University of Science & Technology:Medical Science
关键词 真核质粒 表达时效 基因治疗 eucaryon plasmid expressive time gene therapy
  • 相关文献

参考文献4

  • 1Lee ES, Kim D, Youn YS, et al. A virus - mimetic nanogel ve- hicle[ J]. Angew Chem Int Ed Engl, 2008, 47 (13) : 2418 - 2421.
  • 2胡伊乐,曹靖,任秀花,徐玉英,臧卫东.pEGFP-C3-PENK/NIH3T3表达的脑啡肽对神经细胞PKA表达的影响[J].郑州大学学报(医学版),2010,45(2):269-272. 被引量:2
  • 3Rizzi A, Spagnolo B, Wainford RD, et al. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist se- lective for the nociceptin/orphanin FQ receptor [ J ]. Peptides, 2007, 28(6) :1240 - 1251.
  • 4Smith RR, Martin-Schild S, Kastin A J, et al. Decreases in endo- morphin-2-1ike immunoreactivity concomitant with chronic pain after nerve injury[ J]. Neurosc ,2001, 105 ( 3 ) :773 - 778.

二级参考文献12

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部